Share on StockTwits

Acceleron Pharma (NASDAQ:XLRN) Director Jean George sold 25,477 shares of the company’s stock in a transaction dated Tuesday, June 24th. The stock was sold at an average price of $35.16, for a total value of $895,771.32. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Acceleron Pharma (NASDAQ:XLRN) traded down 3.21% during mid-day trading on Tuesday, hitting $33.50. 189,861 shares of the company’s stock traded hands. Acceleron Pharma has a 1-year low of $16.78 and a 1-year high of $57.89. The stock’s 50-day moving average is $32.03 and its 200-day moving average is $38.37. The company’s market cap is $1.054 billion.

Acceleron Pharma (NASDAQ:XLRN) last posted its quarterly earnings results on Thursday, May 15th. The company reported ($0.30) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.44) by $0.14. The company had revenue of $3.31 million for the quarter, compared to the consensus estimate of $2.85 million. On average, analysts predict that Acceleron Pharma will post $-1.24 earnings per share for the current fiscal year.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.